LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3.

Shu, Chenggan; Wang, Weiwei; Wu, Lipei; Qi, Chunrun; Yan, Wenhui; Lu, Wenying; Tian, Jiale; Shang, Anquan

Shu, Chenggan; Wang, Weiwei; Wu, Lipei; Qi, Chunrun; Yan, Wenhui; Lu, Wenying; Tian, Jiale; Shang, Anquan.

Afiliação

Shu C; Department of Gynecology, The First People's Hospital of Yancheng, City, Yancheng 224006, P.R. China.
Wang W; Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, 200065, P.R. China.
Wu L; Department of Pathology, Tinghu People's Hospital, Yancheng, 224001, P.R. China.
Qi C; Department of Laboratory Medicine, Dongtai People's Hospital & Dongtai Hospital of Nantong University, Yancheng, 224200, P.R. China.
Yan W; Department of Pathology, Tinghu People's Hospital, Yancheng, 224001, P.R. China.
Lu W; Department of Laboratory Medicine, Tinghu People's Hospital, Yancheng, 224001, P.R. China.
Tian J; Department of Laboratory Medicine, Tinghu People's Hospital, Yancheng, 224001, P.R. China.
Shang A; Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, 200065, P.R. China.

Recent Pat Anticancer Drug Discov ; 18(1): 66-79, 2023.

Article em En | MEDLINE | ID: mdl-35297352

Assuntos

MicroRNAs; Neoplasias Ovarianas; Feminino; Humanos; Neoplasias Ovarianas/genética; MicroRNAs/genética

Palavras-chave

LAMA3; LINC00936; Ovarian cancer; microRNA-221-3p; tumor progression; tumorigenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Limite: Female / Humans Idioma: En Revista: Recent Pat Anticancer Drug Discov Assunto da revista: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google